Amphastar Pharmaceuticals (AMPH) Receives a Hold from Northland Securities

Amphastar Pharmaceuticals (AMPH) Receives a Hold from Northland Securities

datetime
Smarter Analyst
In a report released today, Tim Chiang from Northland Securities maintained a Hold rating on Amphastar Pharmaceuticals (AMPH), with a price target of
Read Article